Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 7.28048686 |
2 | ribosomal small subunit biogenesis (GO:0042274) | 7.20557943 |
3 | translational termination (GO:0006415) | 6.96953211 |
4 | maturation of SSU-rRNA (GO:0030490) | 6.21478650 |
5 | ribosomal large subunit biogenesis (GO:0042273) | 5.97764990 |
6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.96356938 |
7 | translational elongation (GO:0006414) | 5.85780627 |
8 | protein targeting to ER (GO:0045047) | 5.85266972 |
9 | cotranslational protein targeting to membrane (GO:0006613) | 5.83618399 |
10 | ribosomal small subunit assembly (GO:0000028) | 5.75396718 |
11 | DNA deamination (GO:0045006) | 5.70100197 |
12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.57337634 |
13 | protein localization to endoplasmic reticulum (GO:0070972) | 5.55261849 |
14 | viral life cycle (GO:0019058) | 5.43829334 |
15 | cellular protein complex disassembly (GO:0043624) | 5.36333503 |
16 | translational initiation (GO:0006413) | 5.25508599 |
17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.14129533 |
18 | protein complex disassembly (GO:0043241) | 4.61591988 |
19 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.40097976 |
20 | macromolecular complex disassembly (GO:0032984) | 4.36072403 |
21 | translation (GO:0006412) | 4.26429553 |
22 | termination of RNA polymerase III transcription (GO:0006386) | 4.12697703 |
23 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.12697703 |
24 | DNA replication checkpoint (GO:0000076) | 3.99611599 |
25 | protein targeting to membrane (GO:0006612) | 3.95030930 |
26 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.77682886 |
27 | negative regulation of cell killing (GO:0031342) | 3.65605811 |
28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65605811 |
29 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.64114762 |
30 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.63240552 |
31 | cellular component biogenesis (GO:0044085) | 3.62141658 |
32 | spliceosomal complex assembly (GO:0000245) | 3.59065103 |
33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.55893682 |
34 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.54518219 |
35 | rRNA processing (GO:0006364) | 3.50464751 |
36 | mRNA catabolic process (GO:0006402) | 3.46507411 |
37 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.45437170 |
38 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.44477228 |
39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.43957585 |
40 | chaperone-mediated protein transport (GO:0072321) | 3.43181192 |
41 | GMP metabolic process (GO:0046037) | 3.40207873 |
42 | base-excision repair, AP site formation (GO:0006285) | 3.39376072 |
43 | rRNA metabolic process (GO:0016072) | 3.38723370 |
44 | pseudouridine synthesis (GO:0001522) | 3.36669839 |
45 | spliceosomal snRNP assembly (GO:0000387) | 3.35358880 |
46 | ATP synthesis coupled proton transport (GO:0015986) | 3.34662756 |
47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.34662756 |
48 | mature B cell differentiation (GO:0002335) | 3.28673014 |
49 | ncRNA 3-end processing (GO:0043628) | 3.25758116 |
50 | response to interferon-beta (GO:0035456) | 3.22058015 |
51 | RNA catabolic process (GO:0006401) | 3.19923831 |
52 | respiratory electron transport chain (GO:0022904) | 3.18813621 |
53 | deoxyribonucleotide catabolic process (GO:0009264) | 3.16396310 |
54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14800234 |
55 | amino sugar catabolic process (GO:0046348) | 3.14730641 |
56 | amino acid salvage (GO:0043102) | 3.14350548 |
57 | L-methionine salvage (GO:0071267) | 3.14350548 |
58 | L-methionine biosynthetic process (GO:0071265) | 3.14350548 |
59 | proteasome assembly (GO:0043248) | 3.12650239 |
60 | electron transport chain (GO:0022900) | 3.10216913 |
61 | mature B cell differentiation involved in immune response (GO:0002313) | 3.06809015 |
62 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06635644 |
63 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.04823470 |
64 | cytidine deamination (GO:0009972) | 3.03098435 |
65 | cytidine metabolic process (GO:0046087) | 3.03098435 |
66 | cytidine catabolic process (GO:0006216) | 3.03098435 |
67 | DNA damage response, detection of DNA damage (GO:0042769) | 3.01173066 |
68 | protein complex biogenesis (GO:0070271) | 3.00974916 |
69 | protein targeting to mitochondrion (GO:0006626) | 3.00834774 |
70 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.00267290 |
71 | rRNA modification (GO:0000154) | 2.98648994 |
72 | deoxyribose phosphate catabolic process (GO:0046386) | 2.98255394 |
73 | purine nucleotide salvage (GO:0032261) | 2.95820289 |
74 | heme biosynthetic process (GO:0006783) | 2.95759606 |
75 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.88624865 |
76 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.88624865 |
77 | NADH dehydrogenase complex assembly (GO:0010257) | 2.88624865 |
78 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.88197552 |
79 | mitochondrial calcium ion transport (GO:0006851) | 2.85768434 |
80 | protein targeting (GO:0006605) | 2.85682962 |
81 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83009731 |
82 | establishment of protein localization to mitochondrion (GO:0072655) | 2.81280802 |
83 | ribosome biogenesis (GO:0042254) | 2.81223961 |
84 | glucosamine-containing compound catabolic process (GO:1901072) | 2.81128747 |
85 | GDP-mannose metabolic process (GO:0019673) | 2.79438325 |
86 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.78190713 |
87 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.77875125 |
88 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74291359 |
89 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.72658714 |
90 | establishment of protein localization to membrane (GO:0090150) | 2.70810622 |
91 | establishment of protein localization to organelle (GO:0072594) | 2.70390296 |
92 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.68993318 |
93 | protein deneddylation (GO:0000338) | 2.68459900 |
94 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.66559962 |
95 | mitotic metaphase plate congression (GO:0007080) | 2.66524674 |
96 | regulation of mitochondrial translation (GO:0070129) | 2.65926467 |
97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.65003861 |
98 | GTP biosynthetic process (GO:0006183) | 2.65001802 |
99 | folic acid metabolic process (GO:0046655) | 2.64876491 |
100 | cellular response to interleukin-15 (GO:0071350) | 2.63391903 |
101 | 7-methylguanosine mRNA capping (GO:0006370) | 2.61512510 |
102 | immunoglobulin mediated immune response (GO:0016064) | 2.61429900 |
103 | peptidyl-histidine modification (GO:0018202) | 2.61066666 |
104 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.59993433 |
105 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.59630926 |
106 | negative regulation of ligase activity (GO:0051352) | 2.59364804 |
107 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59364804 |
108 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.58823468 |
109 | positive regulation of defense response to virus by host (GO:0002230) | 2.58714877 |
110 | DNA replication initiation (GO:0006270) | 2.57779438 |
111 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.56537273 |
112 | positive regulation of viral transcription (GO:0050434) | 2.55545047 |
113 | purine-containing compound salvage (GO:0043101) | 2.54084355 |
114 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.52995142 |
115 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.52995142 |
116 | RNA capping (GO:0036260) | 2.52666613 |
117 | 7-methylguanosine RNA capping (GO:0009452) | 2.52666613 |
118 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.52269052 |
119 | protein localization to mitochondrion (GO:0070585) | 2.52088799 |
120 | cellular response to interferon-beta (GO:0035458) | 2.51816730 |
121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.51809247 |
122 | sarcomere organization (GO:0045214) | 2.51368245 |
123 | negative T cell selection (GO:0043383) | 2.50169603 |
124 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.49357821 |
125 | actin nucleation (GO:0045010) | 2.49272509 |
126 | blastocyst development (GO:0001824) | 2.48789098 |
127 | UTP biosynthetic process (GO:0006228) | 2.47889891 |
128 | ncRNA processing (GO:0034470) | 2.47633746 |
129 | heme metabolic process (GO:0042168) | 2.47275950 |
130 | negative regulation of viral genome replication (GO:0045071) | 2.46762925 |
131 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.46255187 |
132 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.46255187 |
133 | negative regulation of innate immune response (GO:0045824) | 2.45237722 |
134 | rRNA methylation (GO:0031167) | 2.44632989 |
135 | protein neddylation (GO:0045116) | 2.44632737 |
136 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.44521999 |
137 | iron-sulfur cluster assembly (GO:0016226) | 2.44090037 |
138 | metallo-sulfur cluster assembly (GO:0031163) | 2.44090037 |
139 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.43077870 |
140 | leukocyte aggregation (GO:0070486) | 2.42955766 |
141 | DNA strand elongation (GO:0022616) | 2.42791276 |
142 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.42657104 |
143 | interferon-gamma production (GO:0032609) | 2.42534934 |
144 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.42321247 |
145 | transcription from RNA polymerase III promoter (GO:0006383) | 2.41868492 |
146 | glycine metabolic process (GO:0006544) | 2.41415705 |
147 | transcription from RNA polymerase I promoter (GO:0006360) | 2.40937469 |
148 | negative regulation of interleukin-12 production (GO:0032695) | 2.40901569 |
149 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.40193831 |
150 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.40193831 |
151 | DNA-templated transcription, elongation (GO:0006354) | 2.38922451 |
152 | telomere maintenance via recombination (GO:0000722) | 2.38224199 |
153 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.37175232 |
154 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.36814569 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.00107039 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.46769796 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.36621908 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.29625020 |
5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.26855717 |
6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.24729629 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.20196910 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.16663721 |
9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.06595364 |
10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.05326055 |
11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.95024199 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.77261573 |
13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66776620 |
14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.52783548 |
15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.47898114 |
16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.43070659 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41285537 |
18 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22525791 |
19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.20759048 |
20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12345975 |
21 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.11207120 |
22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05490681 |
23 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03088392 |
24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.99865912 |
25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.99457735 |
26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98603610 |
27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98541690 |
28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.97121708 |
29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95300570 |
30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.84844733 |
31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84778362 |
32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83093776 |
33 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76634955 |
34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76474204 |
35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.72944324 |
36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71981278 |
37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.71856689 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71015820 |
39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70110910 |
40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.69882854 |
41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67859997 |
42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66302407 |
43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63522167 |
44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.60249443 |
45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.59727971 |
46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53296423 |
47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53185230 |
48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50628213 |
49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48926212 |
50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.47945762 |
51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46695063 |
52 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45314893 |
53 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.44787309 |
54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42946725 |
55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42254253 |
56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42025228 |
57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40195982 |
58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37317861 |
59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36485785 |
60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35874440 |
61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32243696 |
62 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32112232 |
63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31561643 |
64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.30027206 |
65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.29590575 |
66 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29488461 |
67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29302615 |
68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27535940 |
69 | MYB_26560356_Chip-Seq_TH2_Human | 1.27243565 |
70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26402083 |
71 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26316144 |
72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25723392 |
73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21490755 |
74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21352892 |
75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21023847 |
76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20974335 |
77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20335456 |
78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19395608 |
79 | * P68_20966046_ChIP-Seq_HELA_Human | 1.19092711 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18998110 |
81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18660392 |
82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16336826 |
83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.16103044 |
84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16006291 |
85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15687612 |
86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15405088 |
87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15146157 |
88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14939540 |
89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13429448 |
90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13373455 |
91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13251657 |
92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11220775 |
93 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11116662 |
94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10956031 |
95 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10880968 |
96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07947164 |
97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07850274 |
98 | * MAF_26560356_Chip-Seq_TH2_Human | 1.07498964 |
99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07402419 |
100 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07245016 |
101 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07068351 |
102 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06771105 |
103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06501771 |
104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06046296 |
105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05977126 |
106 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05947518 |
107 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05612010 |
108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04616410 |
109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03156638 |
110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03073326 |
111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02813961 |
112 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01774115 |
113 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01643831 |
114 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00181691 |
115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99909445 |
116 | MYB_26560356_Chip-Seq_TH1_Human | 0.99194015 |
117 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99150236 |
118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98214390 |
119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97718261 |
120 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97543061 |
121 | MYC_22102868_ChIP-Seq_BL_Human | 0.97216028 |
122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95367373 |
123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92058579 |
124 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.90728521 |
125 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90197378 |
126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90079839 |
127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89433375 |
128 | MAF_26560356_Chip-Seq_TH1_Human | 0.89310874 |
129 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89218110 |
130 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89122253 |
131 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88948166 |
132 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88403085 |
133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88378826 |
134 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87450152 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 3.70844651 |
2 | MP0003011_delayed_dark_adaptation | 3.38861484 |
3 | MP0003693_abnormal_embryo_hatching | 3.30551434 |
4 | MP0009379_abnormal_foot_pigmentation | 3.24793704 |
5 | MP0003436_decreased_susceptibility_to | 3.20080758 |
6 | MP0002148_abnormal_hypersensitivity_rea | 2.86309578 |
7 | MP0001835_abnormal_antigen_presentation | 2.85769372 |
8 | MP0005000_abnormal_immune_tolerance | 2.78626943 |
9 | MP0009785_altered_susceptibility_to | 2.67646772 |
10 | MP0001800_abnormal_humoral_immune | 2.45885612 |
11 | MP0002723_abnormal_immune_serum | 2.44904889 |
12 | MP0005025_abnormal_response_to | 2.37744643 |
13 | MP0005387_immune_system_phenotype | 2.32872991 |
14 | MP0001790_abnormal_immune_system | 2.32872991 |
15 | MP0002420_abnormal_adaptive_immunity | 2.32136910 |
16 | MP0004381_abnormal_hair_follicle | 2.30662080 |
17 | MP0001819_abnormal_immune_cell | 2.29039413 |
18 | MP0000750_abnormal_muscle_regeneration | 2.28046671 |
19 | MP0002452_abnormal_antigen_presenting | 2.25987860 |
20 | MP0002419_abnormal_innate_immunity | 2.23175377 |
21 | MP0009840_abnormal_foam_cell | 2.22671905 |
22 | MP0009333_abnormal_splenocyte_physiolog | 2.20811472 |
23 | MP0002653_abnormal_ependyma_morphology | 2.18667038 |
24 | MP0002132_abnormal_respiratory_system | 2.09321498 |
25 | MP0009764_decreased_sensitivity_to | 2.02515382 |
26 | MP0006082_CNS_inflammation | 1.98017752 |
27 | MP0002277_abnormal_respiratory_mucosa | 1.94323980 |
28 | MP0002398_abnormal_bone_marrow | 1.91532422 |
29 | MP0004957_abnormal_blastocyst_morpholog | 1.89456040 |
30 | MP0000716_abnormal_immune_system | 1.88600384 |
31 | MP0002837_dystrophic_cardiac_calcinosis | 1.85143471 |
32 | MP0005330_cardiomyopathy | 1.83670893 |
33 | MP0003077_abnormal_cell_cycle | 1.80468201 |
34 | MP0003111_abnormal_nucleus_morphology | 1.80432652 |
35 | MP0001533_abnormal_skeleton_physiology | 1.80305448 |
36 | MP0002405_respiratory_system_inflammati | 1.76871517 |
37 | MP0003646_muscle_fatigue | 1.73121137 |
38 | MP0004084_abnormal_cardiac_muscle | 1.71602278 |
39 | MP0003806_abnormal_nucleotide_metabolis | 1.70092258 |
40 | MP0003136_yellow_coat_color | 1.68234514 |
41 | MP0000749_muscle_degeneration | 1.67856006 |
42 | MP0001845_abnormal_inflammatory_respons | 1.64817767 |
43 | MP0003718_maternal_effect | 1.62660770 |
44 | MP0003828_pulmonary_edema | 1.57513143 |
45 | MP0008932_abnormal_embryonic_tissue | 1.56455924 |
46 | MP0008260_abnormal_autophagy | 1.53483934 |
47 | MP0005464_abnormal_platelet_physiology | 1.53421425 |
48 | MP0000465_gastrointestinal_hemorrhage | 1.50358885 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.49720048 |
50 | MP0005058_abnormal_lysosome_morphology | 1.48173840 |
51 | MP0008469_abnormal_protein_level | 1.47600388 |
52 | MP0008007_abnormal_cellular_replicative | 1.47401187 |
53 | MP0004147_increased_porphyrin_level | 1.46611156 |
54 | MP0003303_peritoneal_inflammation | 1.44203507 |
55 | MP0005083_abnormal_biliary_tract | 1.43946927 |
56 | MP0000343_altered_response_to | 1.39414830 |
57 | MP0003878_abnormal_ear_physiology | 1.31674287 |
58 | MP0005377_hearing/vestibular/ear_phenot | 1.31674287 |
59 | MP0004947_skin_inflammation | 1.30606209 |
60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28627181 |
61 | MP0003724_increased_susceptibility_to | 1.28451556 |
62 | MP0004215_abnormal_myocardial_fiber | 1.28067899 |
63 | MP0005451_abnormal_body_composition | 1.26804514 |
64 | MP0003137_abnormal_impulse_conducting | 1.23050088 |
65 | MP0010094_abnormal_chromosome_stability | 1.23011213 |
66 | MP0004510_myositis | 1.21528957 |
67 | MP0008058_abnormal_DNA_repair | 1.20830992 |
68 | MP0002102_abnormal_ear_morphology | 1.17468246 |
69 | MP0010630_abnormal_cardiac_muscle | 1.16261256 |
70 | MP0008995_early_reproductive_senescence | 1.16060999 |
71 | MP0010155_abnormal_intestine_physiology | 1.15897380 |
72 | MP0004036_abnormal_muscle_relaxation | 1.13007057 |
73 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09096019 |
74 | MP0003186_abnormal_redox_activity | 1.08368881 |
75 | MP0009763_increased_sensitivity_to | 1.08239841 |
76 | MP0009278_abnormal_bone_marrow | 1.07758700 |
77 | MP0003315_abnormal_perineum_morphology | 1.07433551 |
78 | MP0005645_abnormal_hypothalamus_physiol | 1.05500695 |
79 | MP0002933_joint_inflammation | 1.05029627 |
80 | MP0003075_altered_response_to | 1.04755211 |
81 | MP0000490_abnormal_crypts_of | 1.03836251 |
82 | MP0001542_abnormal_bone_strength | 1.03399465 |
83 | MP0002396_abnormal_hematopoietic_system | 1.03006472 |
84 | MP0005332_abnormal_amino_acid | 0.98730966 |
85 | MP0001663_abnormal_digestive_system | 0.97732416 |
86 | MP0004087_abnormal_muscle_fiber | 0.97658265 |
87 | MP0000566_synostosis | 0.96330179 |
88 | MP0006138_congestive_heart_failure | 0.94547836 |
89 | MP0000751_myopathy | 0.94224958 |
90 | MP0000613_abnormal_salivary_gland | 0.94153101 |
91 | MP0005409_darkened_coat_color | 0.93240226 |
92 | MP0001853_heart_inflammation | 0.92817088 |
93 | MP0001544_abnormal_cardiovascular_syste | 0.92538043 |
94 | MP0005385_cardiovascular_system_phenoty | 0.92538043 |
95 | MP0003191_abnormal_cellular_cholesterol | 0.92353222 |
96 | MP0003786_premature_aging | 0.91245240 |
97 | MP0002106_abnormal_muscle_physiology | 0.90005657 |
98 | MP0001764_abnormal_homeostasis | 0.89759636 |
99 | MP0000372_irregular_coat_pigmentation | 0.89668024 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.89489037 |
101 | MP0003950_abnormal_plasma_membrane | 0.89398374 |
102 | MP0005257_abnormal_intraocular_pressure | 0.89073006 |
103 | MP0005397_hematopoietic_system_phenotyp | 0.88487255 |
104 | MP0001545_abnormal_hematopoietic_system | 0.88487255 |
105 | MP0006035_abnormal_mitochondrial_morpho | 0.87480381 |
106 | MP0001730_embryonic_growth_arrest | 0.87399620 |
107 | MP0003763_abnormal_thymus_physiology | 0.86686538 |
108 | MP0003638_abnormal_response/metabolism_ | 0.86398159 |
109 | MP0004185_abnormal_adipocyte_glucose | 0.84432069 |
110 | MP0009643_abnormal_urine_homeostasis | 0.84143109 |
111 | MP0003866_abnormal_defecation | 0.82858212 |
112 | MP0000350_abnormal_cell_proliferation | 0.82779672 |
113 | MP0004145_abnormal_muscle_electrophysio | 0.82307202 |
114 | MP0000747_muscle_weakness | 0.81996972 |
115 | MP0001919_abnormal_reproductive_system | 0.81954335 |
116 | MP0003656_abnormal_erythrocyte_physiolo | 0.81646038 |
117 | MP0005636_abnormal_mineral_homeostasis | 0.81604231 |
118 | MP0000703_abnormal_thymus_morphology | 0.81198894 |
119 | MP0000313_abnormal_cell_death | 0.80816530 |
120 | MP0001243_abnormal_dermal_layer | 0.80582829 |
121 | MP0005390_skeleton_phenotype | 0.80119347 |
122 | MP0001905_abnormal_dopamine_level | 0.79383791 |
123 | MP0002722_abnormal_immune_system | 0.79361913 |
124 | MP0008775_abnormal_heart_ventricle | 0.78870695 |
125 | MP0001873_stomach_inflammation | 0.78404192 |
126 | MP0004043_abnormal_pH_regulation | 0.77151431 |
127 | MP0002163_abnormal_gland_morphology | 0.76969891 |
128 | MP0005666_abnormal_adipose_tissue | 0.76572123 |
129 | MP0005075_abnormal_melanosome_morpholog | 0.76146690 |
130 | MP0000049_abnormal_middle_ear | 0.74279970 |
131 | MP0000689_abnormal_spleen_morphology | 0.73978926 |
132 | MP0005319_abnormal_enzyme/_coenzyme | 0.72672560 |
133 | MP0002736_abnormal_nociception_after | 0.71822494 |
134 | MP0002080_prenatal_lethality | 0.71761643 |
135 | MP0000759_abnormal_skeletal_muscle | 0.71753407 |
136 | MP0001672_abnormal_embryogenesis/_devel | 0.71715673 |
137 | MP0005380_embryogenesis_phenotype | 0.71715673 |
138 | MP0000604_amyloidosis | 0.71466635 |
139 | MP0000428_abnormal_craniofacial_morphol | 0.70602883 |
140 | MP0002088_abnormal_embryonic_growth/wei | 0.70476354 |
141 | MP0001697_abnormal_embryo_size | 0.70289580 |
142 | MP0005023_abnormal_wound_healing | 0.69255593 |
143 | MP0006292_abnormal_olfactory_placode | 0.69108345 |
144 | MP0003984_embryonic_growth_retardation | 0.68630249 |
145 | MP0002019_abnormal_tumor_incidence | 0.67960794 |
146 | MP0005084_abnormal_gallbladder_morpholo | 0.67827005 |
147 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67384943 |
148 | MP0006072_abnormal_retinal_apoptosis | 0.66898887 |
149 | MP0002972_abnormal_cardiac_muscle | 0.66791488 |
150 | MP0002127_abnormal_cardiovascular_syste | 0.66539662 |
151 | MP0008873_increased_physiological_sensi | 0.66536731 |
152 | MP0002429_abnormal_blood_cell | 0.66340545 |
153 | MP0000647_abnormal_sebaceous_gland | 0.66195847 |
154 | MP0000685_abnormal_immune_system | 0.65892481 |
155 | MP0002269_muscular_atrophy | 0.65359641 |
156 | MP0000858_altered_metastatic_potential | 0.64303905 |
157 | MP0005369_muscle_phenotype | 0.64137007 |
158 | MP0003448_altered_tumor_morphology | 0.63706197 |
159 | MP0005389_reproductive_system_phenotype | 0.63639040 |
160 | MP0004130_abnormal_muscle_cell | 0.63578660 |
161 | MP0005410_abnormal_fertilization | 0.63055198 |
162 | MP0002877_abnormal_melanocyte_morpholog | 0.61877007 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.84358662 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 4.67781482 |
3 | Reticulocytopenia (HP:0001896) | 4.50915368 |
4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.47301767 |
5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.47301767 |
6 | Macrocytic anemia (HP:0001972) | 4.32756836 |
7 | Testicular atrophy (HP:0000029) | 4.08168783 |
8 | Hepatocellular necrosis (HP:0001404) | 3.76385260 |
9 | Hepatic necrosis (HP:0002605) | 3.67481028 |
10 | Mitochondrial inheritance (HP:0001427) | 3.61266935 |
11 | Stomatitis (HP:0010280) | 3.58123189 |
12 | Acute necrotizing encephalopathy (HP:0006965) | 3.54212839 |
13 | Abnormal hemoglobin (HP:0011902) | 3.51689067 |
14 | Aplastic anemia (HP:0001915) | 3.47139618 |
15 | Concave nail (HP:0001598) | 3.45600945 |
16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.33343914 |
17 | Ventricular tachycardia (HP:0004756) | 3.32221773 |
18 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.29417211 |
19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29126804 |
20 | Pallor (HP:0000980) | 3.25536774 |
21 | Acute encephalopathy (HP:0006846) | 3.24971901 |
22 | IgG deficiency (HP:0004315) | 3.22002750 |
23 | Exertional dyspnea (HP:0002875) | 3.17285687 |
24 | Increased IgM level (HP:0003496) | 3.16399473 |
25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.13185975 |
26 | Progressive muscle weakness (HP:0003323) | 3.11134965 |
27 | Increased CSF lactate (HP:0002490) | 3.10970005 |
28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.06806777 |
29 | 3-Methylglutaconic aciduria (HP:0003535) | 3.04049727 |
30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.01770589 |
31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.01770589 |
32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.01770589 |
33 | Sudden death (HP:0001699) | 2.95651279 |
34 | Myositis (HP:0100614) | 2.95480275 |
35 | Cerebral hypomyelination (HP:0006808) | 2.93805540 |
36 | Increased muscle lipid content (HP:0009058) | 2.92157719 |
37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91833181 |
38 | Progressive external ophthalmoplegia (HP:0000590) | 2.87920291 |
39 | Increased hepatocellular lipid droplets (HP:0006565) | 2.85537778 |
40 | Multiple enchondromatosis (HP:0005701) | 2.84565089 |
41 | Recurrent abscess formation (HP:0002722) | 2.81645584 |
42 | Increased serum lactate (HP:0002151) | 2.79891790 |
43 | Abnormality of macrophages (HP:0004311) | 2.78370547 |
44 | Muscle fiber splitting (HP:0003555) | 2.78362168 |
45 | Lipid accumulation in hepatocytes (HP:0006561) | 2.75996899 |
46 | Breast hypoplasia (HP:0003187) | 2.74339851 |
47 | Respiratory failure (HP:0002878) | 2.71491194 |
48 | Progressive macrocephaly (HP:0004481) | 2.69544290 |
49 | Mediastinal lymphadenopathy (HP:0100721) | 2.66690885 |
50 | Cerebral edema (HP:0002181) | 2.65066941 |
51 | Renal Fanconi syndrome (HP:0001994) | 2.64197456 |
52 | Secondary amenorrhea (HP:0000869) | 2.62369466 |
53 | Severe combined immunodeficiency (HP:0004430) | 2.57448112 |
54 | Rhabdomyolysis (HP:0003201) | 2.54876489 |
55 | Recurrent bacterial skin infections (HP:0005406) | 2.51891350 |
56 | Lactic acidosis (HP:0003128) | 2.50618558 |
57 | Encephalitis (HP:0002383) | 2.49241574 |
58 | Exercise intolerance (HP:0003546) | 2.48148241 |
59 | Panhypogammaglobulinemia (HP:0003139) | 2.47604179 |
60 | Microretrognathia (HP:0000308) | 2.47056998 |
61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.46960524 |
62 | Generalized aminoaciduria (HP:0002909) | 2.46649292 |
63 | Petechiae (HP:0000967) | 2.45548586 |
64 | Abnormality of T cells (HP:0002843) | 2.43346103 |
65 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.42253868 |
66 | Oral leukoplakia (HP:0002745) | 2.41887688 |
67 | Abnormality of renal resorption (HP:0011038) | 2.39928792 |
68 | Pancytopenia (HP:0001876) | 2.39030662 |
69 | Obstructive lung disease (HP:0006536) | 2.34864370 |
70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34864370 |
71 | Recurrent fungal infections (HP:0002841) | 2.34573775 |
72 | Type I transferrin isoform profile (HP:0003642) | 2.33500174 |
73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30070480 |
74 | Dicarboxylic aciduria (HP:0003215) | 2.30070480 |
75 | Lipoatrophy (HP:0100578) | 2.28464102 |
76 | Orchitis (HP:0100796) | 2.27406428 |
77 | Dilated cardiomyopathy (HP:0001644) | 2.27171166 |
78 | Combined immunodeficiency (HP:0005387) | 2.26709346 |
79 | CNS demyelination (HP:0007305) | 2.25661372 |
80 | Abnormality of glycolysis (HP:0004366) | 2.24900577 |
81 | Increased serum pyruvate (HP:0003542) | 2.24900577 |
82 | Retrobulbar optic neuritis (HP:0100654) | 2.24582430 |
83 | Optic neuritis (HP:0100653) | 2.24582430 |
84 | Eczematoid dermatitis (HP:0000976) | 2.23573112 |
85 | Hyperglycinemia (HP:0002154) | 2.22921610 |
86 | T lymphocytopenia (HP:0005403) | 2.20758933 |
87 | Lethargy (HP:0001254) | 2.19672052 |
88 | Abnormality of T cell physiology (HP:0011840) | 2.16491618 |
89 | Pustule (HP:0200039) | 2.14964044 |
90 | Trismus (HP:0000211) | 2.14738822 |
91 | Increased serum ferritin (HP:0003281) | 2.13585423 |
92 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.13568571 |
93 | Progressive microcephaly (HP:0000253) | 2.13082443 |
94 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10119712 |
95 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10119712 |
96 | Abnormal protein glycosylation (HP:0012346) | 2.10119712 |
97 | Abnormal glycosylation (HP:0012345) | 2.10119712 |
98 | Hyperglycinuria (HP:0003108) | 2.09146814 |
99 | Rough bone trabeculation (HP:0100670) | 2.08152977 |
100 | Optic disc pallor (HP:0000543) | 2.07754920 |
101 | Areflexia of lower limbs (HP:0002522) | 2.05508972 |
102 | Ragged-red muscle fibers (HP:0003200) | 2.03435864 |
103 | Premature rupture of membranes (HP:0001788) | 2.03066106 |
104 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02753155 |
105 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.02210244 |
106 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.99553890 |
107 | Hypertensive crisis (HP:0100735) | 1.99239055 |
108 | Atrioventricular block (HP:0001678) | 1.98668623 |
109 | Carpal bone hypoplasia (HP:0001498) | 1.98580859 |
110 | Abnormality of iron homeostasis (HP:0011031) | 1.98545665 |
111 | Purpura (HP:0000979) | 1.98312598 |
112 | Triphalangeal thumb (HP:0001199) | 1.97692357 |
113 | Opisthotonus (HP:0002179) | 1.97257389 |
114 | Respiratory difficulties (HP:0002880) | 1.96967379 |
115 | Abnormality of T cell number (HP:0011839) | 1.95986760 |
116 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.95625911 |
117 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94906758 |
118 | Abnormality of glycine metabolism (HP:0010895) | 1.94906758 |
119 | Birth length less than 3rd percentile (HP:0003561) | 1.93591189 |
120 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.92587619 |
121 | Cerebral palsy (HP:0100021) | 1.92425518 |
122 | Achilles tendon contracture (HP:0001771) | 1.92160669 |
123 | Constricted visual fields (HP:0001133) | 1.91901659 |
124 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90290613 |
125 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.90223075 |
126 | Brushfield spots (HP:0001088) | 1.90165601 |
127 | Vacuolated lymphocytes (HP:0001922) | 1.88593774 |
128 | Nausea (HP:0002018) | 1.88512544 |
129 | Entropion (HP:0000621) | 1.88410074 |
130 | Decreased subcutaneous fat (HP:0001002) | 1.88074182 |
131 | Premature ovarian failure (HP:0008209) | 1.87793321 |
132 | Horseshoe kidney (HP:0000085) | 1.86724582 |
133 | Recurrent skin infections (HP:0001581) | 1.86496308 |
134 | Progressive neurologic deterioration (HP:0002344) | 1.86035966 |
135 | Microvesicular hepatic steatosis (HP:0001414) | 1.84687224 |
136 | Hepatosplenomegaly (HP:0001433) | 1.84416952 |
137 | Recurrent cutaneous fungal infections (HP:0011370) | 1.84324617 |
138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.84324617 |
139 | Meningitis (HP:0001287) | 1.84311638 |
140 | Delayed CNS myelination (HP:0002188) | 1.84139182 |
141 | Patellar aplasia (HP:0006443) | 1.83597017 |
142 | Methylmalonic aciduria (HP:0012120) | 1.81495689 |
143 | Calf muscle hypertrophy (HP:0008981) | 1.80318996 |
144 | Seborrheic dermatitis (HP:0001051) | 1.79819357 |
145 | Abnormality of the Achilles tendon (HP:0005109) | 1.79301635 |
146 | Sparse lateral eyebrow (HP:0005338) | 1.78560673 |
147 | Congenital, generalized hypertrichosis (HP:0004540) | 1.78033347 |
148 | Redundant skin (HP:0001582) | 1.77761395 |
149 | Palpitations (HP:0001962) | 1.76796511 |
150 | Ileus (HP:0002595) | 1.76197719 |
151 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.75843598 |
152 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.73514431 |
153 | Emotional lability (HP:0000712) | 1.71706209 |
154 | Abnormality of serum amino acid levels (HP:0003112) | 1.68661892 |
155 | Glycosuria (HP:0003076) | 1.68415376 |
156 | Abnormality of urine glucose concentration (HP:0011016) | 1.68415376 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TLK1 | 5.04887288 |
2 | NME2 | 4.20205776 |
3 | TAOK3 | 3.78498440 |
4 | STK16 | 3.70105292 |
5 | VRK2 | 3.35844267 |
6 | BUB1 | 3.28510186 |
7 | TESK2 | 3.06004725 |
8 | TXK | 2.88936235 |
9 | EIF2AK1 | 2.63938863 |
10 | GRK6 | 2.21061299 |
11 | DYRK3 | 2.20040553 |
12 | TAOK2 | 2.11328710 |
13 | WEE1 | 2.10438493 |
14 | PIM2 | 2.01496107 |
15 | KDR | 1.98960761 |
16 | TIE1 | 1.94125628 |
17 | SRPK1 | 1.80227551 |
18 | IKBKB | 1.71774348 |
19 | MAP3K14 | 1.54692421 |
20 | PRPF4B | 1.50969596 |
21 | IRAK3 | 1.50018399 |
22 | MAP3K10 | 1.47880390 |
23 | PBK | 1.45944295 |
24 | MKNK2 | 1.42876026 |
25 | IKBKE | 1.40809972 |
26 | MAP3K11 | 1.37537582 |
27 | BMPR1B | 1.36914842 |
28 | BCKDK | 1.35429948 |
29 | ILK | 1.30330582 |
30 | LIMK1 | 1.27544879 |
31 | SCYL2 | 1.27510720 |
32 | NME1 | 1.23516526 |
33 | ACVR1B | 1.21653153 |
34 | PHKG2 | 1.18913540 |
35 | PHKG1 | 1.18913540 |
36 | NEK2 | 1.15207238 |
37 | CDK7 | 1.12177935 |
38 | FES | 1.10159177 |
39 | TTK | 1.09400075 |
40 | CDK19 | 1.08126559 |
41 | DAPK3 | 1.07118245 |
42 | DYRK1B | 1.06333517 |
43 | RPS6KA4 | 1.05327246 |
44 | MAP3K3 | 1.05295294 |
45 | DMPK | 1.03969599 |
46 | MYLK | 1.03468267 |
47 | TTN | 1.02507973 |
48 | CSK | 1.01215641 |
49 | LRRK2 | 0.99669525 |
50 | MATK | 0.99219778 |
51 | AURKA | 0.97080818 |
52 | CSF1R | 0.96652819 |
53 | TESK1 | 0.96516402 |
54 | TNK2 | 0.96366752 |
55 | MST4 | 0.95855035 |
56 | TEC | 0.94984835 |
57 | LYN | 0.93986759 |
58 | TAOK1 | 0.93973292 |
59 | AURKB | 0.93945161 |
60 | TRIB3 | 0.93332840 |
61 | ITK | 0.92273140 |
62 | MAP4K1 | 0.91538544 |
63 | MAP2K3 | 0.90451826 |
64 | ADRBK2 | 0.90051981 |
65 | IRAK2 | 0.89952357 |
66 | EIF2AK3 | 0.89539128 |
67 | MAP3K12 | 0.89049247 |
68 | JAK3 | 0.88545253 |
69 | BLK | 0.87914758 |
70 | VRK1 | 0.86494433 |
71 | DYRK2 | 0.86426508 |
72 | PLK1 | 0.85632020 |
73 | TGFBR1 | 0.84175130 |
74 | RPS6KA5 | 0.83474222 |
75 | MUSK | 0.83148906 |
76 | MAP2K7 | 0.81692601 |
77 | LCK | 0.81373927 |
78 | DAPK1 | 0.81302201 |
79 | STK4 | 0.81178411 |
80 | ZAP70 | 0.80162288 |
81 | SYK | 0.79814542 |
82 | CDK4 | 0.78246730 |
83 | GRK7 | 0.76610124 |
84 | TBK1 | 0.74857558 |
85 | IRAK1 | 0.74574660 |
86 | MAPKAPK3 | 0.73897793 |
87 | PKN1 | 0.73096266 |
88 | MKNK1 | 0.72553936 |
89 | CDK8 | 0.71680684 |
90 | SIK3 | 0.70282859 |
91 | TYK2 | 0.70199344 |
92 | STK10 | 0.69507369 |
93 | ZAK | 0.67374472 |
94 | HCK | 0.67194041 |
95 | NUAK1 | 0.67171409 |
96 | PRKCQ | 0.66863887 |
97 | PAK1 | 0.65232318 |
98 | MAP3K8 | 0.62687543 |
99 | LATS2 | 0.61880248 |
100 | MAPK15 | 0.61819078 |
101 | CHUK | 0.60961844 |
102 | MAP2K2 | 0.60266384 |
103 | CHEK2 | 0.59691430 |
104 | PAK2 | 0.58911214 |
105 | NEK9 | 0.58192777 |
106 | IRAK4 | 0.57538799 |
107 | ERN1 | 0.56589937 |
108 | CCNB1 | 0.56253262 |
109 | BRAF | 0.55958021 |
110 | RPS6KB2 | 0.55522876 |
111 | PRKCI | 0.55176459 |
112 | GRK1 | 0.54882775 |
113 | MARK3 | 0.54741705 |
114 | CAMKK2 | 0.54195352 |
115 | TGFBR2 | 0.53953538 |
116 | STK39 | 0.53493790 |
117 | PRKD2 | 0.53057261 |
118 | PRKD1 | 0.52326870 |
119 | PKN2 | 0.52012467 |
120 | EIF2AK2 | 0.50179270 |
121 | OBSCN | 0.49010932 |
122 | KIT | 0.46980702 |
123 | MAPKAPK5 | 0.45761765 |
124 | EPHA2 | 0.45019449 |
125 | CAMK2D | 0.44122594 |
126 | NLK | 0.43534823 |
127 | MAP4K2 | 0.43398387 |
128 | SIK2 | 0.43375069 |
129 | BRSK2 | 0.42898573 |
130 | PIM1 | 0.41860849 |
131 | MAPKAPK2 | 0.41720883 |
132 | CSNK2A1 | 0.40319913 |
133 | CSNK1G3 | 0.40202383 |
134 | PDK4 | 0.39972195 |
135 | PDK3 | 0.39972195 |
136 | MAP3K5 | 0.38750854 |
137 | MAP3K1 | 0.37670750 |
138 | EPHB2 | 0.37407330 |
139 | ABL2 | 0.37098381 |
140 | BRD4 | 0.36818912 |
141 | ABL1 | 0.36545122 |
142 | BTK | 0.36443255 |
143 | WNK4 | 0.36246172 |
144 | CSNK2A2 | 0.34300886 |
145 | ADRBK1 | 0.31354346 |
146 | ARAF | 0.29019781 |
147 | PRKCD | 0.28390662 |
148 | RPS6KA6 | 0.27756523 |
149 | SMG1 | 0.25180956 |
150 | RIPK4 | 0.24417947 |
151 | RPS6KL1 | 0.24112954 |
152 | RPS6KC1 | 0.24112954 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 5.67282414 |
2 | RNA polymerase_Homo sapiens_hsa03020 | 3.68204210 |
3 | Sulfur relay system_Homo sapiens_hsa04122 | 2.77278333 |
4 | Proteasome_Homo sapiens_hsa03050 | 2.69278455 |
5 | DNA replication_Homo sapiens_hsa03030 | 2.62671998 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58079166 |
7 | Spliceosome_Homo sapiens_hsa03040 | 2.46837726 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.42069665 |
9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.30671132 |
10 | Homologous recombination_Homo sapiens_hsa03440 | 2.18397249 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.15504664 |
12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05324160 |
13 | Protein export_Homo sapiens_hsa03060 | 2.02808173 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95235095 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94320462 |
16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.91904628 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88285928 |
18 | Mismatch repair_Homo sapiens_hsa03430 | 1.85688602 |
19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83511343 |
20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.73475622 |
21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.57710429 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54129354 |
23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53399141 |
24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51601144 |
25 | Asthma_Homo sapiens_hsa05310 | 1.51085192 |
26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50592960 |
27 | Base excision repair_Homo sapiens_hsa03410 | 1.48156768 |
28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47025836 |
29 | RNA transport_Homo sapiens_hsa03013 | 1.41756735 |
30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41692757 |
31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38729932 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38147201 |
33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36734309 |
34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32968129 |
35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32644631 |
36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31832905 |
37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30815643 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30441447 |
39 | Purine metabolism_Homo sapiens_hsa00230 | 1.28766276 |
40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28469430 |
41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25891596 |
42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25355958 |
43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.24766602 |
44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20454183 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20231195 |
46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20156524 |
47 | Cell cycle_Homo sapiens_hsa04110 | 1.14265997 |
48 | Shigellosis_Homo sapiens_hsa05131 | 1.11869566 |
49 | Legionellosis_Homo sapiens_hsa05134 | 1.11759608 |
50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08012753 |
51 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07953711 |
52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07281699 |
53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06834321 |
54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06668861 |
55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06036549 |
56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04706403 |
57 | Measles_Homo sapiens_hsa05162 | 1.01438400 |
58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01408727 |
59 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01371649 |
60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99203084 |
61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94785916 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92776690 |
63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.90562899 |
64 | Tuberculosis_Homo sapiens_hsa05152 | 0.89027924 |
65 | Lysosome_Homo sapiens_hsa04142 | 0.88380444 |
66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87025253 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86719100 |
68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86327276 |
69 | Malaria_Homo sapiens_hsa05144 | 0.86086580 |
70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85245865 |
71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83942309 |
72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82762263 |
73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81968401 |
74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81826913 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80691443 |
76 | RNA degradation_Homo sapiens_hsa03018 | 0.78741457 |
77 | Salmonella infection_Homo sapiens_hsa05132 | 0.78554380 |
78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78204087 |
79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77795784 |
80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74989846 |
81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73108099 |
82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71745586 |
83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71191338 |
84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71107445 |
85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70940064 |
86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69867563 |
87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69568293 |
88 | Peroxisome_Homo sapiens_hsa04146 | 0.68280580 |
89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68136801 |
90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66078328 |
91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64961437 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62794364 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61997028 |
94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61655196 |
95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61418736 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.61327783 |
97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61292157 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.60418971 |
99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60090423 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60013535 |
101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59177806 |
102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57393226 |
103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57098167 |
104 | Bladder cancer_Homo sapiens_hsa05219 | 0.55289346 |
105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55183764 |
106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52948568 |
107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50681256 |
108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50019660 |
109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49220795 |
110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49055508 |
111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48432699 |
112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48303972 |
113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47778932 |
114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45348237 |
115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44765222 |
116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43627610 |
117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43110781 |
118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40899732 |
119 | Phagosome_Homo sapiens_hsa04145 | 0.39873336 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39744033 |
121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38253266 |
122 | Hepatitis B_Homo sapiens_hsa05161 | 0.37407342 |
123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37060712 |
124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34864601 |
125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34561250 |
126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33673344 |
127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32993232 |
128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32630586 |
129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32171333 |
130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30173802 |
131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29472280 |
132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29024156 |
133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28598302 |
134 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28496389 |
135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27161653 |
136 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26592164 |
137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26349774 |
138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26215031 |
139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25694292 |
140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22659636 |
141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21651196 |
142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20682637 |
143 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20604100 |
144 | Apoptosis_Homo sapiens_hsa04210 | 0.20140720 |